Back
Surmodics, Inc. 10K Form
Buy
56
SRDX
Surmodics, Inc.
Last Price:
$42.98
Seasonality Move:
3.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | SRDX/Surmodics, Inc. Quarterly |
| 2024-02-01 | 10Q | SRDX/Surmodics, Inc. Quarterly |
| 2023-08-02 | 10Q | SRDX/Surmodics, Inc. Quarterly |
| 2023-04-26 | 10Q | SRDX/Surmodics, Inc. Quarterly |
| 2023-02-06 | 10Q | SRDX/Surmodics, Inc. Quarterly |
| 2022-07-27 | 10Q | SRDX/Surmodics, Inc. Quarterly |
Receive SRDX News And Ratings
See the #1 stock for the next 7 days that we like better than SRDX
SRDX Financial Statistics
Sales & Book Value
| Annual Sales: | $126.1M |
|---|---|
| Cash Flow: | $904K |
| Price / Cash Flow: | 20.84 |
| Annual Sales: | $7.78 |
| Price / Book: | 5.52 |
Profitability
| EPS (TTM): | -1.23000 |
|---|---|
| Net Income (TTM): | $-17.6M |
| Gross Margin: | $89.6M |
| Return on Equity: | -15.45% |
| Return on Assets: | -10.34% |
Surmodics, Inc. Earnings Forecast
Key Surmodics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 29 years for SRDX is 71.03%.
-
The Selling, General & Administrative Expenses for SRDX have been equal to 45.08% of Gross Profit Margin.
-
The Research & Development expenses have been 30.43% of Revenue.
-
The Net Earning history of SRDX is -9.15% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 16 years.
Surmodics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | SRDX |
| CUSIP: | 868873 |
| Website: | surmodics.com |
Debt
| Debt-to-Equity Ratio: | 0.29 |
|---|---|
| Current Ratio: | 3.91 |
| Quick Ratio: | 2.85 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 153.5 |
SRDX Technical Analysis vs Fundamental Analysis
Buy
56
Surmodics, Inc. (SRDX)
is a Buy
Is Surmodics, Inc. a Buy or a Sell?
-
Surmodics, Inc. stock is rated a BuyThe current Surmodics, Inc. [SRDX] share price is $42.98. The Score for SRDX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.